0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Derivative Product Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-3V8115
Home | Market Reports | Health| Pharmacy
Global Blood Derivative Product Market Insights and Forecast to 2028
BUY CHAPTERS

Global Blood Derivative Product Market Research Report 2025

Code: QYRE-Auto-3V8115
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Derivative Product Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Blood Derivative Product Market

Blood Derivative Product Market

The global market for Blood Derivative Product was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Derivative Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Derivative Product.
The Blood Derivative Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Derivative Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Derivative Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Blood Derivative Product Market Report

Report Metric Details
Report Name Blood Derivative Product Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Pfizer, Inc, Bristol-Myers Squibb Company, Leo Pharma A/S, Sanofi, Fusion Health Care, AstraZeneca Plc, Baxter International Inc, BDI Pharma, SK Plasma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Blood Derivative Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Blood Derivative Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Blood Derivative Product Market report?

Ans: The main players in the Blood Derivative Product Market are GlaxoSmithKline, Pfizer, Inc, Bristol-Myers Squibb Company, Leo Pharma A/S, Sanofi, Fusion Health Care, AstraZeneca Plc, Baxter International Inc, BDI Pharma, SK Plasma

What are the Application segmentation covered in the Blood Derivative Product Market report?

Ans: The Applications covered in the Blood Derivative Product Market report are Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants, Other

What are the Type segmentation covered in the Blood Derivative Product Market report?

Ans: The Types covered in the Blood Derivative Product Market report are Albumin, Coagulation Factor Concentrates, Immunoglobulins, Other

Recommended Reports

Blood Devices

Blood Consumables

Blood Testing

1 Blood Derivative Product Market Overview
1.1 Product Definition
1.2 Blood Derivative Product by Type
1.2.1 Global Blood Derivative Product Market Value Comparison by Type (2024 VS 2031)
1.2.2 Albumin
1.2.3 Coagulation Factor Concentrates
1.2.4 Immunoglobulins
1.2.5 Other
1.3 Blood Derivative Product by Application
1.3.1 Global Blood Derivative Product Market Value by Application (2024 VS 2031)
1.3.2 Platelet Aggregation Inhibitors
1.3.3 Fibrinolytics
1.3.4 Anticoagulants
1.3.5 Other
1.4 Global Blood Derivative Product Market Size Estimates and Forecasts
1.4.1 Global Blood Derivative Product Revenue 2020-2031
1.4.2 Global Blood Derivative Product Sales 2020-2031
1.4.3 Global Blood Derivative Product Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Blood Derivative Product Market Competition by Manufacturers
2.1 Global Blood Derivative Product Sales Market Share by Manufacturers (2020-2025)
2.2 Global Blood Derivative Product Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Blood Derivative Product Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Blood Derivative Product, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blood Derivative Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Derivative Product, Product Type & Application
2.7 Global Key Manufacturers of Blood Derivative Product, Date of Enter into This Industry
2.8 Global Blood Derivative Product Market Competitive Situation and Trends
2.8.1 Global Blood Derivative Product Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Blood Derivative Product Players Market Share by Revenue
2.8.3 Global Blood Derivative Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood Derivative Product Market Scenario by Region
3.1 Global Blood Derivative Product Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Blood Derivative Product Sales by Region: 2020-2031
3.2.1 Global Blood Derivative Product Sales by Region: 2020-2025
3.2.2 Global Blood Derivative Product Sales by Region: 2026-2031
3.3 Global Blood Derivative Product Revenue by Region: 2020-2031
3.3.1 Global Blood Derivative Product Revenue by Region: 2020-2025
3.3.2 Global Blood Derivative Product Revenue by Region: 2026-2031
3.4 North America Blood Derivative Product Market Facts & Figures by Country
3.4.1 North America Blood Derivative Product Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Blood Derivative Product Sales by Country (2020-2031)
3.4.3 North America Blood Derivative Product Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood Derivative Product Market Facts & Figures by Country
3.5.1 Europe Blood Derivative Product Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Blood Derivative Product Sales by Country (2020-2031)
3.5.3 Europe Blood Derivative Product Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Derivative Product Market Facts & Figures by Region
3.6.1 Asia Pacific Blood Derivative Product Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Blood Derivative Product Sales by Region (2020-2031)
3.6.3 Asia Pacific Blood Derivative Product Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood Derivative Product Market Facts & Figures by Country
3.7.1 Latin America Blood Derivative Product Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Blood Derivative Product Sales by Country (2020-2031)
3.7.3 Latin America Blood Derivative Product Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Derivative Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Derivative Product Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Blood Derivative Product Sales by Country (2020-2031)
3.8.3 Middle East and Africa Blood Derivative Product Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blood Derivative Product Sales by Type (2020-2031)
4.1.1 Global Blood Derivative Product Sales by Type (2020-2025)
4.1.2 Global Blood Derivative Product Sales by Type (2026-2031)
4.1.3 Global Blood Derivative Product Sales Market Share by Type (2020-2031)
4.2 Global Blood Derivative Product Revenue by Type (2020-2031)
4.2.1 Global Blood Derivative Product Revenue by Type (2020-2025)
4.2.2 Global Blood Derivative Product Revenue by Type (2026-2031)
4.2.3 Global Blood Derivative Product Revenue Market Share by Type (2020-2031)
4.3 Global Blood Derivative Product Price by Type (2020-2031)
5 Segment by Application
5.1 Global Blood Derivative Product Sales by Application (2020-2031)
5.1.1 Global Blood Derivative Product Sales by Application (2020-2025)
5.1.2 Global Blood Derivative Product Sales by Application (2026-2031)
5.1.3 Global Blood Derivative Product Sales Market Share by Application (2020-2031)
5.2 Global Blood Derivative Product Revenue by Application (2020-2031)
5.2.1 Global Blood Derivative Product Revenue by Application (2020-2025)
5.2.2 Global Blood Derivative Product Revenue by Application (2026-2031)
5.2.3 Global Blood Derivative Product Revenue Market Share by Application (2020-2031)
5.3 Global Blood Derivative Product Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Blood Derivative Product Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Company Information
6.2.2 Pfizer, Inc Description and Business Overview
6.2.3 Pfizer, Inc Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer, Inc Blood Derivative Product Product Portfolio
6.2.5 Pfizer, Inc Recent Developments/Updates
6.3 Bristol-Myers Squibb Company
6.3.1 Bristol-Myers Squibb Company Company Information
6.3.2 Bristol-Myers Squibb Company Description and Business Overview
6.3.3 Bristol-Myers Squibb Company Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bristol-Myers Squibb Company Blood Derivative Product Product Portfolio
6.3.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.4 Leo Pharma A/S
6.4.1 Leo Pharma A/S Company Information
6.4.2 Leo Pharma A/S Description and Business Overview
6.4.3 Leo Pharma A/S Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Leo Pharma A/S Blood Derivative Product Product Portfolio
6.4.5 Leo Pharma A/S Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Blood Derivative Product Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Fusion Health Care
6.6.1 Fusion Health Care Company Information
6.6.2 Fusion Health Care Description and Business Overview
6.6.3 Fusion Health Care Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fusion Health Care Blood Derivative Product Product Portfolio
6.6.5 Fusion Health Care Recent Developments/Updates
6.7 AstraZeneca Plc
6.7.1 AstraZeneca Plc Company Information
6.7.2 AstraZeneca Plc Description and Business Overview
6.7.3 AstraZeneca Plc Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca Plc Blood Derivative Product Product Portfolio
6.7.5 AstraZeneca Plc Recent Developments/Updates
6.8 Baxter International Inc
6.8.1 Baxter International Inc Company Information
6.8.2 Baxter International Inc Description and Business Overview
6.8.3 Baxter International Inc Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Baxter International Inc Blood Derivative Product Product Portfolio
6.8.5 Baxter International Inc Recent Developments/Updates
6.9 BDI Pharma
6.9.1 BDI Pharma Company Information
6.9.2 BDI Pharma Description and Business Overview
6.9.3 BDI Pharma Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BDI Pharma Blood Derivative Product Product Portfolio
6.9.5 BDI Pharma Recent Developments/Updates
6.10 SK Plasma
6.10.1 SK Plasma Company Information
6.10.2 SK Plasma Description and Business Overview
6.10.3 SK Plasma Blood Derivative Product Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SK Plasma Blood Derivative Product Product Portfolio
6.10.5 SK Plasma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Derivative Product Industry Chain Analysis
7.2 Blood Derivative Product Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Derivative Product Production Mode & Process Analysis
7.4 Blood Derivative Product Sales and Marketing
7.4.1 Blood Derivative Product Sales Channels
7.4.2 Blood Derivative Product Distributors
7.5 Blood Derivative Product Customer Analysis
8 Blood Derivative Product Market Dynamics
8.1 Blood Derivative Product Industry Trends
8.2 Blood Derivative Product Market Drivers
8.3 Blood Derivative Product Market Challenges
8.4 Blood Derivative Product Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Blood Derivative Product Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Blood Derivative Product Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Blood Derivative Product Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Blood Derivative Product Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Blood Derivative Product Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Blood Derivative Product Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Blood Derivative Product Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Blood Derivative Product Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Blood Derivative Product, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Blood Derivative Product, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Blood Derivative Product, Product Type & Application
 Table 12. Global Key Manufacturers of Blood Derivative Product, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Blood Derivative Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Derivative Product as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Blood Derivative Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Blood Derivative Product Sales by Region (2020-2025) & (K Units)
 Table 18. Global Blood Derivative Product Sales Market Share by Region (2020-2025)
 Table 19. Global Blood Derivative Product Sales by Region (2026-2031) & (K Units)
 Table 20. Global Blood Derivative Product Sales Market Share by Region (2026-2031)
 Table 21. Global Blood Derivative Product Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Blood Derivative Product Revenue Market Share by Region (2020-2025)
 Table 23. Global Blood Derivative Product Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Blood Derivative Product Revenue Market Share by Region (2026-2031)
 Table 25. North America Blood Derivative Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Blood Derivative Product Sales by Country (2020-2025) & (K Units)
 Table 27. North America Blood Derivative Product Sales by Country (2026-2031) & (K Units)
 Table 28. North America Blood Derivative Product Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Blood Derivative Product Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Blood Derivative Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Blood Derivative Product Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Blood Derivative Product Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Blood Derivative Product Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Blood Derivative Product Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Blood Derivative Product Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Blood Derivative Product Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Blood Derivative Product Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Blood Derivative Product Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Blood Derivative Product Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Blood Derivative Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Blood Derivative Product Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Blood Derivative Product Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Blood Derivative Product Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Blood Derivative Product Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Blood Derivative Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Blood Derivative Product Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Blood Derivative Product Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Blood Derivative Product Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Blood Derivative Product Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Blood Derivative Product Sales (K Units) by Type (2020-2025)
 Table 51. Global Blood Derivative Product Sales (K Units) by Type (2026-2031)
 Table 52. Global Blood Derivative Product Sales Market Share by Type (2020-2025)
 Table 53. Global Blood Derivative Product Sales Market Share by Type (2026-2031)
 Table 54. Global Blood Derivative Product Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Blood Derivative Product Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Blood Derivative Product Revenue Market Share by Type (2020-2025)
 Table 57. Global Blood Derivative Product Revenue Market Share by Type (2026-2031)
 Table 58. Global Blood Derivative Product Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Blood Derivative Product Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Blood Derivative Product Sales (K Units) by Application (2020-2025)
 Table 61. Global Blood Derivative Product Sales (K Units) by Application (2026-2031)
 Table 62. Global Blood Derivative Product Sales Market Share by Application (2020-2025)
 Table 63. Global Blood Derivative Product Sales Market Share by Application (2026-2031)
 Table 64. Global Blood Derivative Product Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Blood Derivative Product Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Blood Derivative Product Revenue Market Share by Application (2020-2025)
 Table 67. Global Blood Derivative Product Revenue Market Share by Application (2026-2031)
 Table 68. Global Blood Derivative Product Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Blood Derivative Product Price (US$/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Blood Derivative Product Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Pfizer, Inc Company Information
 Table 76. Pfizer, Inc Description and Business Overview
 Table 77. Pfizer, Inc Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer, Inc Blood Derivative Product Product
 Table 79. Pfizer, Inc Recent Developments/Updates
 Table 80. Bristol-Myers Squibb Company Company Information
 Table 81. Bristol-Myers Squibb Company Description and Business Overview
 Table 82. Bristol-Myers Squibb Company Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bristol-Myers Squibb Company Blood Derivative Product Product
 Table 84. Bristol-Myers Squibb Company Recent Developments/Updates
 Table 85. Leo Pharma A/S Company Information
 Table 86. Leo Pharma A/S Description and Business Overview
 Table 87. Leo Pharma A/S Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Leo Pharma A/S Blood Derivative Product Product
 Table 89. Leo Pharma A/S Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Blood Derivative Product Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Fusion Health Care Company Information
 Table 96. Fusion Health Care Description and Business Overview
 Table 97. Fusion Health Care Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Fusion Health Care Blood Derivative Product Product
 Table 99. Fusion Health Care Recent Developments/Updates
 Table 100. AstraZeneca Plc Company Information
 Table 101. AstraZeneca Plc Description and Business Overview
 Table 102. AstraZeneca Plc Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. AstraZeneca Plc Blood Derivative Product Product
 Table 104. AstraZeneca Plc Recent Developments/Updates
 Table 105. Baxter International Inc Company Information
 Table 106. Baxter International Inc Description and Business Overview
 Table 107. Baxter International Inc Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Baxter International Inc Blood Derivative Product Product
 Table 109. Baxter International Inc Recent Developments/Updates
 Table 110. BDI Pharma Company Information
 Table 111. BDI Pharma Description and Business Overview
 Table 112. BDI Pharma Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. BDI Pharma Blood Derivative Product Product
 Table 114. BDI Pharma Recent Developments/Updates
 Table 115. SK Plasma Company Information
 Table 116. SK Plasma Description and Business Overview
 Table 117. SK Plasma Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. SK Plasma Blood Derivative Product Product
 Table 119. SK Plasma Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Blood Derivative Product Distributors List
 Table 123. Blood Derivative Product Customers List
 Table 124. Blood Derivative Product Market Trends
 Table 125. Blood Derivative Product Market Drivers
 Table 126. Blood Derivative Product Market Challenges
 Table 127. Blood Derivative Product Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Blood Derivative Product
 Figure 2. Global Blood Derivative Product Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Blood Derivative Product Market Share by Type: 2024 & 2031
 Figure 4. Albumin Product Picture
 Figure 5. Coagulation Factor Concentrates Product Picture
 Figure 6. Immunoglobulins Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Blood Derivative Product Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Blood Derivative Product Market Share by Application: 2024 & 2031
 Figure 10. Platelet Aggregation Inhibitors
 Figure 11. Fibrinolytics
 Figure 12. Anticoagulants
 Figure 13. Other
 Figure 14. Global Blood Derivative Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Blood Derivative Product Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Blood Derivative Product Sales (2020-2031) & (K Units)
 Figure 17. Global Blood Derivative Product Average Price (US$/Unit) & (2020-2031)
 Figure 18. Blood Derivative Product Report Years Considered
 Figure 19. Blood Derivative Product Sales Share by Manufacturers in 2024
 Figure 20. Global Blood Derivative Product Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Blood Derivative Product Players: Market Share by Revenue in Blood Derivative Product in 2024
 Figure 22. Blood Derivative Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Blood Derivative Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Blood Derivative Product Sales Market Share by Country (2020-2031)
 Figure 25. North America Blood Derivative Product Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Blood Derivative Product Sales Market Share by Country (2020-2031)
 Figure 29. Europe Blood Derivative Product Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Blood Derivative Product Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Blood Derivative Product Revenue Market Share by Region (2020-2031)
 Figure 37. China Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Blood Derivative Product Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Blood Derivative Product Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Blood Derivative Product Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Blood Derivative Product Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Blood Derivative Product Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Blood Derivative Product by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Blood Derivative Product by Type (2020-2031)
 Figure 59. Global Blood Derivative Product Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Blood Derivative Product by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Blood Derivative Product by Application (2020-2031)
 Figure 62. Global Blood Derivative Product Price (US$/Unit) by Application (2020-2031)
 Figure 63. Blood Derivative Product Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Jet Lag Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0R20253
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart